Accentia Biopharmace (ABPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,653 | -12,223 | -8,488 | -7,460 | -48,211 |
| Depreciation Amortization | 562 | 410 | 271 | 134 | 987 |
| Accounts receivable | 71 | 94 | 445 | 122 | 1,478 |
| Accounts payable and accrued liabilities | 480 | 503 | 557 | 522 | -741 |
| Other Working Capital | 2,995 | 1,784 | 1,030 | 55 | 6,239 |
| Other Operating Activity | 18,487 | 4,976 | 3,705 | 5,325 | 39,828 |
| Operating Cash Flow | $6,942 | $-4,456 | $-2,480 | $-1,302 | $-420 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -789 | -684 | -150 | -98 | -72 |
| Investing Cash Flow | $-789 | $-684 | $-150 | $-98 | $-72 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,250 | 250 | 250 | 250 | N/A |
| Debt Issued | 7,353 | 7,353 | 7,000 | 7,000 | 640 |
| Common Stock Issued | 6 | 6 | 6 | 6 | N/A |
| Other Financing Activity | -2,842 | -1,659 | -2,655 | -2,650 | 86 |
| Financing Cash Flow | $6,767 | $5,950 | $4,601 | $4,606 | $726 |
| Beginning Cash Position | 559 | 559 | 559 | 559 | 325 |
| End Cash Position | 421 | 1,368 | 2,529 | 3,764 | 559 |
| Net Cash Flow | $-138 | $810 | $1,971 | $3,206 | $233 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,942 | -4,456 | -2,480 | -1,302 | -420 |
| Capital Expenditure | -789 | -684 | -150 | -98 | -72 |
| Free Cash Flow | 6,153 | -5,140 | -2,630 | -1,400 | -492 |